Cytokeratin 5 antibody
-
- Target See all Cytokeratin 5 (KRT5) Antibodies
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
-
Reactivity
- Human
-
Host
-
Guinea Pig
-
Clonality
- Polyclonal
-
Conjugate
- This Cytokeratin 5 antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Purity
- Stabilized antiserum
- Immunogen
- Cytokeratin 5 antibody was raised in guinea pig using recombinant human keratin K5 as the immunogen.
- Top Product
- Discover our top product KRT5 Primary Antibody
-
-
- Application Notes
- IHC-F: 1:100, IHC-P: 1:50, WB: 1:5,000-1:10,000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Suppleid as a liquid with 0.09 % NaN3 and 0.5 % BSA.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
- Storage
- 4 °C
- Storage Comment
- Store at 4 °C
-
-
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." in: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
: "p73 regulates epidermal wound healing and induced keratinocyte programming." in: PLoS ONE, Vol. 14, Issue 6, pp. e0218458, (2019) (PubMed).
: "
-
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." in: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
-
- Target
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
- Alternative Name
- Cytokeratin 5 (KRT5 Products)
-